Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and Women
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether circulating metabolic intermediates are related to insulin resistance and β-cell dysfunction in individuals at risk for type 2 diabetes. RESEARCH DESIGN AND METHODS: In 73 sedentary, overweight to obese, dyslipidemic individuals, insulin action was derived from a frequently sampled intravenous glucose tolerance test. Plasma concentrations of 75 amino acids, acylcarnitines, free fatty acids, and conventional metabolites were measured with a targeted, mass spectrometry–based platform. Principal components analysis followed by backward stepwise linear regression was used to explore relationships between measures of insulin action and metabolic intermediates. RESULTS: The 75 metabolic intermediates clustered into 19 factors comprising biologically related intermediates. A factor containing large neutral amino acids was inversely related to insulin sensitivity (SI) (R2 = 0.26). A factor containing fatty acids was inversely related to the acute insulin response to glucose (R2 = 0.12). Both of these factors, age, and a factor containing medium-chain acylcarnitines and glucose were inversely and independently related to the disposition index (DI) (R2 = 0.39). Sex differences were found for metabolic predictors of SI and DI. CONCLUSIONS: In addition to the well-recognized risks for insulin resistance, elevated concentrations of large, neutral amino acids were independently associated with insulin resistance. Fatty acids were inversely related to the pancreatic response to glucose. Both large neutral amino acids and fatty acids were related to an appropriate pancreatic response, suggesting that these metabolic intermediates might play a role in the progression to type 2 diabetes, one by contributing to insulin resistance and the other to pancreatic failure. These intermediates might exert sex-specific effects on insulin action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similar abnormalities in acylcarnitine accumulation and incomplete β-oxidation have been identified in humans with obesity or type 2 diabetes (Adams et al., 2009; Huffman et al., 2009; Mihalik et al., 2010) and in primary human skeletal myocytes derived from obese compared to lean subjects (Bell et al., 2010; Kovalik et al., 2011).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Huffman et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human studies have also reported increased plasma acylcarnitine levels in association with insulin resistance and diabetes [1,37,52,64].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [37]
Experimental — accuracy not yet measuredIn the citing paper
“Our findings, which highlight five branched chain and aromatic amino acids from 61 metabolites profiled, are particularly noteworthy in the context of experimental and clinical data suggesting that certain amino acids may be both markers and effectors of insulin resistance14,15,18,20,21.”
From Metabolite profiles and the risk of developing diabetes (2011) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Self-citationMechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes
Cnop, M., Welsh, N., Jonas, J.-C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s97 · Cited by 1,491
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
Self-citationPlasma Amino Acid Levels and Insulin Secretion in Obesity
Felig, P., Marliss, E., & Cahill, G. F. (1969) · New England Journal of Medicine · doi:10.1056/nejm196910092811503 · Cited by 812
(1922) · PubMed · Cited by 753
Effect of the volume and intensity of exercise training on insulin sensitivity
Houmard, J. A., Tanner, C. J., Slentz, C. A., Duscha, B. D., McCartney, J. S., & Kraus, W. E. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00707.2003 · Cited by 568
Self-citationKashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Berria, R., Pratipanawatr, W., Bajaj, M., Mandarino, L., DeFronzo, R., & Cusi, K. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2461 · Cited by 503
Bidirectional modulation of insulin action by amino acids.
Patti, M. E., Brambilla, E., Luzi, L., Landaker, E. J., & Kahn, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1326 · Cited by 493
Mechanism of Amino Acid-Induced Skeletal Muscle Insulin Resistance in Humans
Krebs, M., Krssak, M., Bernroider, E., Anderwald, C., Brehm, A., Meyerspeer, M., Nowotny, P., Roth, E., Waldhäusl, W., & Roden, M. (2002) · Diabetes · doi:10.2337/diabetes.51.3.599 · Cited by 392
Draznin, B. (2006) · Diabetes · doi:10.2337/db06-0391 · Cited by 388
The “Thrifty Genotype” in 19981
Neel, J. V. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1999.tb01782.x · Cited by 321
Carpentier, A., Mittelman, S. D., Bergman, R. N., Giacca, A., & Lewis, G. F. (2000) · Diabetes · doi:10.2337/diabetes.49.3.399 · Cited by 226
Moran, A., Jacobs, D. R., Steinberger, J., Steffen, L. M., Pankow, J. S., Hong, C.-P., & Sinaiko, A. R. (2008) · Circulation · doi:10.1161/circulationaha.107.704569 · Cited by 223
Plasma Amino Acid Levels and Insulin Secretion in Obesity
Felig, P. (1970) · Laboratory Medicine · doi:10.1093/labmed/1.9.39 · Cited by 212
Pancreatic Extracts in the Treatment of Diabetes Mellitus: Preliminary Report.
Banting, F., BEST, C. H., Collip, J. B., et al. (1962) · PubMed · Cited by 181
Decreased Susceptibility to Fatty Acid–Induced Peripheral Tissue Insulin Resistance in Women
Frias, J. P., Macaraeg, G. B., Ofrecio, J., Yu, J. G., Olefsky, J. M., & Kruszynska, Y. T. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1344 · Cited by 162
Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis
Flanagan, D., Moore, V., Godsland, I. F., Cockington, R. A., Robinson, J. S., & Phillips, D. I. W. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.4.e700 · Cited by 154
Gender-specific programming of insulin secretion and action
Sugden, M. C., & Holness, M. J. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750757 · Cited by 138
Boucher, A., Lu, D., Burgess, S. C., Telemaque-Potts, S., Jensen, M. V., Mulder, H., Wang, M.-Y., Unger, R. H., Sherry, A. D., & Newgard, C. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401167200 · Cited by 136
Self-citationFemale Rats Do Not Exhibit Free Fatty Acid–Induced Insulin Resistance
Hevener, A. L., Reichart, D. R., Janež, A., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1907 · Cited by 133
Orchestration of Glucose Homeostasis
Bergman, R. N. (2007) · Diabetes · doi:10.2337/db07-9903 · Cited by 128
Are the available experimental models of type 2 diabetes appropriate for a gender perspective?
Franconi, F., Seghieri, G., Canu, S., Straface, E., Campesi, I., & Malorni, W. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.11.007 · Cited by 100
Lien, L. F., Haqq, A. M., Arlotto, M., Slentz, C. A., Muehlbauer, M. J., McMahon, R. L., Rochon, J., Gallup, D., Bain, J. R., Ilkayeva, O., et al. (2009) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2008.0035 · Cited by 97
Self-citationDrummond, M. J., Bell, J. A., Fujita, S., Dreyer, H. C., Glynn, E. L., Volpi, E., & Rasmussen, B. B. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.01.012 · Cited by 83
Peyot, M., Nolan, C. J., Soni, K. G., Joly, E. C., Lussier, R., Corkey, B. E., Wang, S. P., Mitchell, G. A., & Prentki, M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1733 · Cited by 77
Haqq, A. M., Lien, L. F., Boan, J., Arlotto, M. E., Slentz, C. A., Muehlbauer, M. J., Rochon, J., Gallup, D. S., McMahon, R. L., Bain, J. R., et al. (2005) · Contemporary Clinical Trials · doi:10.1016/j.cct.2005.09.003 · Cited by 46
Self-citationGender differences in the insulin‐like growth factor axis response to a glucose load
Flanagan, D., Holt, R. I. G., Owens, P. C., Cockington, R. J., Moore, V., Robinson, J. S., Godsland, I. F., & Phillips, D. I. W. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01581.x · Cited by 31
Cited by
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Interplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080
Self-citationSoininen, P., Kangas, A. J., Würtz, P., Suna, T., & Ala-Korpela, M. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000216 · Cited by 900
Metabolomics and Metabolic Diseases: Where Do We Stand?
Newgard, C. B. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.018 · Cited by 750
Self-citationSchooneman, M. G., Vaz, F. M., Houten, S. M., & Soeters, M. R. (2013) · Diabetes · doi:10.2337/db12-0466 · Cited by 616
Metadata
- Authors
- Huffman, K. M., Shah, S. H., Stevens, R. D., Bain, J. R., Muehlbauer, M., Slentz, C. A., Tanner, C. J., Kuchibhatla, M., Houmard, J. A., Newgard, C. B., & Kraus, W. E.
- Affiliations
- Durham VA Medical Center (US)
- Duke University (US)
- Duke Medical Center (US)
- East Carolina University (US)
- Corresponding author
- Huffman, Kim M.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-05
- Volume
- 32
- Issue
- 9
- Pages
- 1678-1683
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2732163
- OpenAlex
- W2118708320
- Cited by
- 410
- References
- 27
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 16 · 2023: 25 · 2022: 24 · 2021: 32 · 2020: 24 · 2019: 25 · 2018: 24 · 2017: 26 · 2016: 35 · 2015: 29 · 2014: 35 · 2013: 37 · 2012: 32
- FWCI
- 14.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (P30 AGO28716-01)
- National Institute on Aging (R01AG028930, AG-028930-01, P30AG028716)
- National Heart, Lung, and Blood Institute (R01 HL 57354, R01HL057354)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23AR054904)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, insulin action, type 2 diabetes risk, large neutral amino acids, free fatty acids, acylcarnitines, insulin sensitivity, disposition index, beta-cell function, acute insulin response, metabolic intermediates, sex differences, overweight and obesity, sedentary adults, dyslipidemia
- MeSH terms
- Adolescent, Adult, Aged, Amino Acids, Blood Glucose, Carnitine, Cross-Sectional Studies, Fatty Acids, Nonesterified, Female, Humans, Insulin Resistance, Male, Gas Chromatography-Mass Spectrometry, Middle Aged, Obesity, Principal Component Analysis, Overweight, Tandem Mass Spectrometry, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
